Commonwealth Equity Services
FTXH icon

Commonwealth Equity Services’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Commonwealth Equity Services’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$247K Buy
7,191
+5
+0.1% +$171 ﹤0.01% 3812
2025
Q4 		$237K Buy
+7,186
New +$224K ﹤0.01% 3841

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Commonwealth Equity Services's FTXH Position: Q1 2026 in Review

Commonwealth Equity Services increased its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 0.07% in Q1 2026, buying an estimated $171 and bringing the position to 7,191 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #3812.

Commonwealth Equity Services first reported a position in FTXH in Q4 2025 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

  • Commonwealth Equity Services held 7,191 shares of First Trust Nasdaq Pharmaceuticals ETF worth $247K as of Q1 2026.
  • Commonwealth Equity Services bought 5 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2026, an estimated $171.
  • First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #3812 holding.
  • Commonwealth Equity Services first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2025 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.